Construction of a Prognostic Gene Signature Associated with Immune Infiltration in Glioma: A Comprehensive Analysis Based on the CGGA

Figure 5

Confirmation of the signature via patient stratification based on specific pathological and molecular features. (a) Grade II; (b) grade III; (c) grade IV; (d) mutated IDH1; (e) wild-type IDH1; (f) 1p/19q codeletion; (g) 1p/19q noncodeletion; (h) MGMT promoter methylated status; (i) MGMT promoter unmethylated status.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)